Jorge Alderete is the President of ALK Americas and Sr. VP, Commercial Operations, the American division of Denmark-based ALK. ALK is a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. 

The company is a proven pioneer in allergy immunotherapy, working to desensitize patients’ immune system and may completely remove one’s allergy symptoms and the need for traditional, symptom-relieving medication.